Table 1: The demographic characteristics of the patients with rectal
gastrointestinal stromal tumors.
|
Contents |
Number |
Percentage (%) |
|
Age (years) |
|
|
|
＜60 |
29 |
59.2 |
|
≥60 |
20 |
40.8 |
|
Gender |
|
|
|
Male |
32 |
65.3 |
|
Female |
17 |
34.7 |
|
Symptoms * |
|
|
|
No symptoms |
17 |
34.7 |
|
Rectal bleeding |
16 |
32.7 |
|
Rectal pain or discomfort |
21 |
42.9 |
|
Difficult defecation |
14 |
28.6 |
|
Change of bowel habits |
20 |
40.8 |
|
Mass protruded |
2 |
4.1 |
|
Urinary Symptoms |
3 |
6.1 |
|
Tumor size (cm) |
|
|
|
＜5 |
24 |
49.0 |
|
≥5 |
25 |
51.0 |
|
Distance from anal verge (cm) |
|
|
|
＜6 |
46 |
93.9 |
|
≥6 |
3 |
6.1 |
|
NIH risk categories |
|
|
|
Very low and low |
18 |
36.7 |
|
Intermediate and high |
31 |
63.3 |
|
Tumor rupture |
1 |
2.0 |
|
Recurrent patients |
9 |
18.4 |
|
Liver metastasis |
2 |
4.1 |
|
Follow-up time (days) |
705 (48-1677) |
|
*Some patients have more than one
symptom. NIH: National Institute of Health.